Thursday, October 25, 2012
Publication and contact
Assays & screens
Multiplex screening for
interacting compounds (MuSIC) to help identify drug combinations to treat
MuSIC could be used to help
identify drug combinations to treat HIV infection. A primary screen using
pooled compounds to increase throughput was used to evaluate about 500,000
drug pairs of 1,000 FDA-approved or clinically tested compounds in
HIV-infected cells. The screen identified the glucocorticoid prednisolone
and the antiprotozoal nitazoxanide as the top synergistic
pair hit. The pair was confirmed by a separate screen and by two distinct
methods to quantify drug synergy. Additional cell-based studies showed that
prednisolone and nitazoxanide synergized with the HIV integrase inhibitor Isentress raltegravir.
Ongoing work includes testing other combinations identified in the study and
using MuSIC to identify combinations that could be used to treat other
infectious diseases, cancer or asthma.
Published online Oct. 25, 2012
status not applicable
Tan, X. et al. Nat.
Biotechnol.; published online Oct.14, 2012;
Contact: Stephen J. Elledge, Harvard Medical School and
Brigham and Women's Hospital, Boston, Mass.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]